Laboratory studies released this week suggest that the Omicron variant of the coronavirus will blunt the power of Pfizer and BioNTech's vaccine to prevent Covid-19 infection after two doses, although a third dose may restore that protection.

Data is still needed on how protective Covid-19 vaccines remain in real-world use against the highly mutated Omicron variant.